Smoking Cessation After a Cancer Diagnosis

H&O Which types of cancer are most strongly linked to smoking? DB Twelve types of cancers are firmly linked to tobacco smoking, according to the […]

Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer Erica L. Mayer, […]

Combination Therapies for Treating Metastatic Melanoma

Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Hussein Tawbi, MD, PhD Associate Professor of Medicine, Clinical & Translational Science, University […]

The Role of Third-Generation Epithelial Growth Factor Receptor Inhibitors in Non–Small Cell Lung Cancer

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Lecia V. Sequist, MD, MPH, Associate Professor, Harvard Medical School, Boston, Massachusetts H&O How did […]

Bevacizumab vs EGFR Antibodies in Metastatic Colorectal Cancer

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2 Alan P. Venook, MD, Professor, Department of Medicine, Hematology/Oncology, University of California, San Francisco H&O […]

The Use of Granulocyte-Macrophage Colony-Stimulating Factor in Melanoma Treatment

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2 F. Stephen Hodi, MD, Associate Professor, Harvard Medical School and Dana-Farber Cancer Institute, Boston, Massachusetts […]

Extending Endocrine Therapy in Women With Hormone Receptor–Positive Breast Cancer

Clinical Advances in Hematology & Oncology January 2015, Volume 13, Issue 1 Paul E. Goss, FRCP, MB BCh, PhD, Professor, Harvard Medical School, Director, Breast Cancer Research, Massachusetts General […]

The Next Generation of Targeted Therapy Trials in Colorectal Cancer

Clinical Advances in Hematology & Oncology December 2014, Volume 12, Issue 12 Peter J. O’Dwyer, MD, Professor of Medicine, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania […]

Immunotherapy for Melanoma Using Programmed Death 1 Checkpoint Inhibitors

Clinical Advances in Hematology & Oncology November 2014, Volume 12, Issue 11 Omid Hamid, MD, Chief of Research/Immuno-Oncology, Director of Melanoma Program, The Angeles Clinic and Research Institute, Los Angeles, […]

The Promise of Liquid Biopsy in Colorectal Cancer

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Luis Alberto Diaz, MD Associate Professor of Oncology, The Johns Hopkins University School of […]

Molecular Profiling for DCIS

Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 Christy A. Russell, MD, Associate Professor of Clinical Medicine, Director of USC Norris Breast Center, Los […]

The Effect of Diet and Supplements on Prostate Cancer

Clinical Advances in Hematology & Oncology August 2014, Volume 12, Issue 8 Stephen J. Freedland, MD Associate Professor of Surgery, Associate Professor in Pathology, Duke University School of […]

Immunoconjugates in the Treatment of Breast Cancer

July 2014, Volume 12, Issue 7 Debu Tripathy, MD Professor of Medicine, Priscilla and Art Ulene Chair in Women’s Cancer, Keck School of Medicine, University of Southern California, Los Angeles, […]

Maintenance Therapy in Metastatic Colorectal Cancer

Clinical Advances in Hematology & Oncology June 2014, Volume 12, Issue 6 John L. Marshall, MD, Chief, Hematology and Oncology, Director, Ruesch Center for the Cure of GI Cancers, Medstar […]

Prostate Cancer in Focus: The Potential Role of Antigen Spread in Immunotherapy for Prostate Cancer

Clinical Advances in Hematology & Oncology May 2014, Volume 12, Issue 5 Charles G. Drake, MD, PhD Associate Professor Oncology, Immunology, and Urology Johns Hopkins Sidney […]

Aspirin, the New Targeted Therapy in Colorectal Cancer

Clinical Advances in Hematology & Oncology March 2014, Volume 12, Issue 3 Charles S. Fuchs, MD, MPH Director, Gastrointestinal Cancer Center Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School, Boston, […]

New Research on the Treatment of Small HER2-Positive Breast Cancers

Clinical Advances in Hematology & Oncology February 2014, Volume 12, Issue 2 New Research on the Treatment of Small HER2-Positive Breast Cancers Ian E. Krop, MD, […]

Colorectal Cancer in Focus: Testing for RAS Mutations in Patients With Metastatic Colorectal Cancer

Clinical Advances in Hematology & Oncology January 2014, Volume 12, Issue 1 Heinz-Josef Lenz, MD Professor of Medicine and Preventive Medicine Division of Medical Oncology Keck School of […]

Breast Cancer in Focus: Management of the Axilla in Breast Cancer Patients Undergoing Neoadjuvant Therapy

Clinical Advances in Hematology & Oncology December 2013, Volume 11, Issue 12 Julia White, MD Professor, Department of Radiation Oncology Director, Breast Radiation Oncology, Stefanie Spielman Comprehensive […]

Radium-223, the Newest Option in Metastatic Castration-Resistant Prostate Cancer

Clinical Advances in Hematology & Oncology December 2013, Volume 11, Issue 12 Radium-223, the Newest Option in Metastatic Castration-Resistant Prostate Cancer Oliver Sartor, MD, LaBorde Professor for […]